FDA approves Vera Therapeutics kidney disease treatment 7.3%
STAT - By Adam Feuerstein - 7/7/2026, 4:44 PM
Optimism Bias 24% - Self-Serving Bias 24% - Appeal to Emotion 24%
The Food and Drug Administration on Tuesday approved a new medicine from the biotech company Vera Therapeutics for patients with a type of chronic autoimmune kidney disease. The drug, called Trutakna, was cleared to treat IgA nephropathy, or IgAN, a disease caused by the buildup of immune antibodies in the kidneys. The condition leads to... more